Artivion Valuation
| AORT Stock | USD 45.81 0.68 1.51% |
At this time, the firm appears to be fairly valued. Artivion shows a prevailing Real Value of $44.7 per share. The current price of the firm is $45.81. Our model approximates the value of Artivion from analyzing the firm fundamentals such as Return On Equity of -0.0246, profit margin of (0.02) %, and Current Valuation of 2.33 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Artivion's price fluctuation is very steady at this time. Calculation of the real value of Artivion is based on 3 months time horizon. Increasing Artivion's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Artivion's intrinsic value may or may not be the same as its current market price of 45.81, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 45.81 | Real 44.7 | Hype 45.81 | Naive 43.54 |
The intrinsic value of Artivion's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Artivion's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Artivion helps investors to forecast how Artivion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Artivion more accurately as focusing exclusively on Artivion's fundamentals will not take into account other important factors: Artivion Total Value Analysis
Artivion is presently projected to have valuation of 2.33 B with market capitalization of 2.14 B, debt of 362.26 M, and cash on hands of 40.38 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Artivion fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.33 B | 2.14 B | 362.26 M | 40.38 M |
Artivion Investor Information
About 91.0% of the company shares are held by institutions such as insurance companies. The book value of Artivion was presently reported as 9.26. The company recorded a loss per share of 0.23. Artivion last dividend was issued on the 9th of December 2015. The entity had 3:2 split on the 28th of December 2000. Based on the analysis of Artivion's profitability, liquidity, and operating efficiency, Artivion is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Artivion Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Artivion has an asset utilization ratio of 49.24 percent. This implies that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that Artivion is more efficient with each dollar of assets it utilizes for everyday operations.Artivion Ownership Allocation
Artivion holds a total of 47.37 Million outstanding shares. The majority of Artivion outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Artivion to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Artivion. Please pay attention to any change in the institutional holdings of Artivion as this could imply that something significant has changed or is about to change at the company. On November 19, 2025, Representative Gilbert Cisneros of US Congress acquired under $15k worth of Artivion's common stock.Artivion Profitability Analysis
The company reported the previous year's revenue of 388.54 M. Net Loss for the year was (13.36 M) with profit before overhead, payroll, taxes, and interest of 272.59 M.About Artivion Valuation
The stock valuation mechanism determines Artivion's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Artivion based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Artivion. We calculate exposure to Artivion's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Artivion's related companies.Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company was founded in 1984 and is headquartered in Kennesaw, Georgia. Artivion operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 1300 people.
Artivion Growth Indicators
Investing in growth stocks can be very risky. If the company such as Artivion does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 41.7 M | |
| Forward Price Earnings | 64.1026 |
Additional Tools for Artivion Stock Analysis
When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.